Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 28 November

Sam Kanaan
November 28, 2023

Morning Bell 27 November

Grady Wulff
November 27, 2023

Weekly Wrap 24 November

Grady Wulff
November 24, 2023

Morning Bell 24 November

Sam Kanaan
November 24, 2023

Morning Bell 23 November

Grady Wulff
November 23, 2023

Morning Bell 22 November

Grady Wulff
November 22, 2023

Morning Bell 21 November

Sam Kannan
November 21, 2023

Morning Bell 20 November

Grady Wulff
November 20, 2023

Weekly Wrap 17 November

Grady Wulff
November 17, 2023

Morning Bell 17 November

Sam Kanaan
November 17, 2023

Morning Bell 16 November

Sam Kanaan
November 16, 2023